Navigation Links
Wayne State University researchers win grant from the NSF to target tinnitus
Date:6/20/2011

DETROIT A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.

With the ever-expanding knowledge in the fields of neuroscience and neurosurgery, there is an increasing need for devices and tools that enable neuroscientists to delve deeper into the physiological and pathological function of neural tissue at the level of groups of neurons. A variety of neural probes developed have significantly contributed to important discoveries within the neuroscience community. Despite this steady progress over the past two decades, there is a strong demand for improved probes with new functionality. The Wayne State team will address this need by developing a 3-D neural probe that simplifies the fabrication and assembly process of high-density 3-D arrays of electrodes.

Yong Xu, Ph.D., associate professor of electrical and computer engineering and resident of Troy, Mich., and Jinsheng Zhang, Ph.D. associate professor and associate research director of otolaryngology, associate professor of communication sciences and disorders, and resident of Troy, said the project, "A novel 3-dimensional neural probe technology combining electrical and chemical interfaces," is based on a flexible skin structure and simple folding procedure. The technology will enable the integration of micro-channels for neurotransmitter-based chemical stimulation and local delivery of various drugs for biocompatibility improvement.

The team aims to develop next generation 3-D neural probes that can electrically and chemically stimulate neurons with greater efficacy and can monitor neural activity from deeper regions of the brain.

"One highly desirable feature is 3-D array of electrodes to monitor or modulate neural activities with 3-D spatial resolution," said Xu. "In addition, it is very advantageous to integrate micro-channels that enable neurotransmitter-based chemical stimulation and local drug delivery to reduce or suppress tissue response, one of the major obstacles for successful chronic implantation. Currently there is no good method of making 3-D array of electrodes, let alone the integration of micro-channels with 3-D arrays of electrodes."

Naturalistic chemical stimulation using integrated micro-channels could address some of the issues concerning pure electrical stimulation of neural probes, such as poor spatial resolution, degradation of metal electrodes, and water hydrolysis due to the large stimulation currents and charges required to depolarize the neuron cells. In addition, the fabrication process is post-complementary metaloxidesemiconductor (CMOS) compatible, allowing the monolithic integration of CMOS circuits with neural probes using an economical post-CMOS process.

"These important features will help us become the leader in the new round of worldwide races to develop the next generation neural probes," said Xu. "The successful development of the implantable device will be useful for treating a variety of neurological disorders, such as refractory paralysis, epilepsy, Parkinson's disease, Alzheimer's disease, blindness and tinnitus."

Xu and Zhang will target tinnitus suppression with the implantable neural probe they are developing. Tinnitus affects 50 million Americans and more than 250 million people worldwide. In the United States alone, approximately three to four million people are debilitated by the condition.

Currently, there is no reliable treatment for tinnitus. Pharmacologic treatment and rehabilitation can improve the emotional and psychological reaction to tinnitus, but this therapy has been unreliable and requires long periods of time and a considerable amount of patient compliance. Recent clinical studies have shown that stimulation of the auditory cortex through transcranial magnetic stimulation or direct electrical stimulation has acute or longer-lasting suppressive effects, providing a new hope in finding an effective and reliable therapy.

"Our recent work has shown that electrical stimulation is a promising method to suppress tinnitus," said Zhang. "Once we better understand the mechanisms underlying electrical and chemical stimulation-induced suppression, we will be fully focused on advancing the engineering fabrication to create a minimally- or even non-invasive medical device for diagnosis and treatment."


'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Wayne State researchers find new way to examine major depressive disorder in children
2. Wayne State leads study to improve management of cancer pain in African Americans
3. Wayne State study links testosterone with mens ability to woo potential mates
4. Wayne State University researchers publish results settling multiple sclerosis debate
5. Speaking the same language means better health care quality, Wayne State University study finds
6. Wayne State University study predicts risk of memory loss in healthy, older adults
7. Community Health Systems, Inc.s Wayne T. Smith and Larry Cash Named Americas Top Healthcare CEO and CFO
8. Experimental Vaccine Seems to Cure Prostate Cancer in Mice
9. Mayo Clinic researchers use human vaccine to cure prostate cancer in mice
10. Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway
11. Penn State receives $27.3 million NIH grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: